Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.4% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$213B
| $1.68B | 2.08% |
49,693,342
-3,989,000
| -7% | -$142M |
|
2
VeriSign
VRSN
$23.8B
| $968M | 1.2% |
4,868,314
-853,220
| -15% | -$168M |
|
3
Zoom
ZM
$24.7B
| $810M | 1.01% |
2,520,863
+132,329
| +6% | +$48.7M |
|
4
Monster Beverage
MNST
$91.5B
| $725M | 0.9% |
15,913,520
-4,545,800
| -22% | -$204M |
|
5
Target
TGT
$61.1B
| $710M | 0.88% |
3,586,059
-1,759,606
| -33% | -$329M |
|
6
Atlassian
TEAM
$20.3B
| $704M | 0.88% |
3,341,420
-1,003,600
| -23% | -$234M |
|
|
7
Baidu
BIDU
$36.5B
| $697M | 0.87% |
3,204,791
-5,385,073
| -63% | -$1.41B |
|
8
Palo Alto Networks
PANW
$265B
| $664M | 0.83% |
12,378,780
-5,937,594
| -32% | -$353M |
|
9
Kroger
KR
$34.2B
| $618M | 0.77% |
17,174,071
-7,473,144
| -30% | -$255M |
|
10
Franco-Nevada
FNV
$41.3B
| $606M | 0.75% |
4,837,390
-705,200
| -13% | -$84.9M |
|
11
Vodafone
VOD
$35.1B
| $595M | 0.74% |
32,310,076
-4,672,900
| -13% | -$84.5M |
|
12
Molina Healthcare
MOH
$10.4B
| $577M | 0.72% |
2,466,415
-633,950
| -20% | -$141M |
|
|
ABMD
13
DELISTED
Abiomed Inc
ABMD
| $567M | 0.71% |
1,780,123
-213,677
| -11% | -$68.4M |
|
|
14
Tesla
TSLA
$1.2T
| $553M | 0.69% |
2,482,143
+1,699,518
| +217% | +$427M |
|
15
Biogen
BIIB
$29.6B
| $542M | 0.67% |
1,938,162
-1,099,600
| -36% | -$297M |
|
16
United Therapeutics
UTHR
$26.4B
| $537M | 0.67% |
3,207,591
-399,700
| -11% | -$66.6M |
|
17
Hershey
HSY
$34.9B
| $532M | 0.66% |
3,361,261
-20,005
| -0.6% | -$3.01M |
|
18
Vertex Pharmaceuticals
VRTX
$120B
| $516M | 0.64% |
2,400,284
-1,175,646
| -33% | -$258M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
| $509M | 0.63% |
3,328,121
-785,583
| -19% | -$122M |
|
20
F5
FFIV
$21.9B
| $500M | 0.62% |
2,397,136
-621,700
| -21% | -$122M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $480M | 0.6% |
5,209,963
-1,589,000
| -23% | -$134M |
|
|
22
Roku
ROKU
$21B
| $474M | 0.59% |
1,455,700
+1,001,745
| +221% | +$393M |
|
23
Etsy
ETSY
$7.68B
| $465M | 0.58% |
2,308,208
-1,521,900
| -40% | -$319M |
|
24
Fortinet
FTNT
$111B
| $447M | 0.56% |
12,123,420
-5,579,000
| -32% | -$183M |
|
25
Alphabet (Google) Class A
GOOGL
$3.88T
| $442M | 0.55% |
4,286,960
+448,000
| +12% | +$44.2M |
|
Similar funds
Renaissance Technologies's Q1 2021 Portfolio in Review
As of Q1 2021, Renaissance Technologies held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Renaissance Technologies opened a new position in Paramount Global Class B worth $255M.
- Renaissance Technologies's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Renaissance Technologies added most to Tesla in Q1 2021, an estimated $427M increase.
- Renaissance Technologies's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Renaissance Technologies fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Renaissance Technologies's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Renaissance Technologies opened 591 new positions and closed 676 in Q1 2021.
- Renaissance Technologies's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.